[1] |
Parkin D M, Bray F, Ferlay J, et al. Global cancer statistics,2002. CA Cancer J Clin,2005,55:74 -108.
|
[2] |
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008.CA Cancer J Clin,2008,58:71 -96.
|
[3] |
张思维,陈万青,孔灵芝,等. 中国部分市县1998 ~2002 年恶性肿瘤的发病与死亡.中国肿瘤,2006,15:430 -448.
|
[4] |
Early Breast Cancer Trialists'Collaborative Group (EBCTCG).Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet,2005,365:1687 -1717.
|
[5] |
Arriagada R,Lê MG,Rochard F,et al. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol,1996,14:1558 -1564.
|
[6] |
Early Breast Cancer Trialists'Collaborative Group. Effects of radiotherapy and surgery in early breast cancer:an overview of the randomized trials. N Engl J Med,1995,333:1444 -1455.
|
[7] |
Fisher B,Anderson S,Bryant J,et al.Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy,and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med,2002,347:1233 -1241.
|
[8] |
Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med,2002,347:1227 -1232.
|
[9] |
Abrams J S, Philips P H, Friedman M A. Meeting highlights:a reappraisal of research results for the local treatment of early stage breast cancer. J Natl Cancer Inst,1995,87:1837 -1845.
|
[10] |
Dalberg K, Mattsson A, Rutqvist L E, et al. Breast conserving surgery for invasive breast cancer: risk factors for ipsilateral breast recurrences. Breast Cancer Res Treat,1997,43:73 -86.
|
[11] |
NIH Consensus Conference. Treatment of early stage breast cancer. JAMA,1991,265:391 -395.
|
[12] |
张保宁,邵志敏,乔新民,等.中国乳腺癌保乳治疗的前瞻性多中心研究.中华肿瘤杂志,2005,27:680 -684.
|
[13] |
张保宁.乳腺癌保乳手术临床应用现状与发展趋势.中国实用外科杂志,2008,28:528 -524.
|
[14] |
Borger J, Kampermann H, Hart A, et al. Risk factors in breast-conservation therapy. J Clin Oncol,1994,12:653 -660.
|
[15] |
Kurtz J M, Jacquemier J, Amalric R, et al. Why are local recurrences after breast-conservation therapy more frequent in younger patients? J Clin Oncol,1990,8:591 -598.
|
[16] |
Veronesi U,Luini A,Del Vecchio M,et al. Radiotherapy after breast-preserving therapy in women with localized cancer of the breast. N Engl J Med,1993,328:1587 -1591.
|
[17] |
Vilcoq J, Calle R, Stacey P, et al. The outcome of treatment by tumorectomy and radiotherapy of patients with operable breast cancer. Int J Radiat Oncol Biol Phys, 1981,7:1327 -1332.
|
[18] |
Fourquet A, Campana F, Zafrani B,et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys,1989,17:719 -725.
|
[19] |
Fisher B, Wickerham D L, Deutsch M, et al. Breast tumor recurrence following lumpectomy with and without breast irradiation: an overview of recent NSABP findings. Semin Surg Oncol,1992,8:153 -160.
|
[20] |
Winchester D P. Breast cancer in young women. Surg Clin North Am,1996,76:279 -287.
|
[21] |
Vezeridis M P, Bland K I. Surgical and medical management of in situ and early stage breast carcinoma. In:Singletary SE,ed.Breast cancer. New York: Springer,1999:132 -148.
|
[22] |
Schwartz G F, Veronesi U, Clough K B, et al. Consensus Conference Committee. Consensus conference on breast conservation. J Am Coll Surg,2006,203:198 -207.
|
[23] |
Fitzal F,Riedl O,Wutzl L,et al. Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patients. Breast Cancer Res Treat,2007,103:45 -52.
|
[24] |
Liljegren G, Lindgren A, Bergh J, et al. Risk factors for local recurrence after conservative treatment in stage I breast cancer:definition of a subgroup not requiring radiotherapy. Ann Oncol,1997,8:235 -241.
|
[25] |
Fisher B, Anderson S, Fisher ER, et al. Significance of ipsilateral breast tumor recurrence after lumpectomy. Lancet,1991,338:327 -331.
|
[26] |
Gazet J C. Future prospects in limited surgery for early breast cancer. Semin Surg Oncol,1996,12:39 -45.
|
[27] |
Soran A, Vogel V. Optimal management of primary breast cancer. Breast J,1999,5:81 -93.
|
[28] |
Danoff B,Goodman RL. Identification of a subgroup of patients with breast cancer in whom conservative surgery and radiation is contraindicated. Int J Radiat Oncol Biol Phys,1985,11 (suppl 1):104.
|
[29] |
Ueda S, Tamaki Y, Yano K, et al. Cosmetic outcome and patient satisfaction after skin-sparing mastectomy for breast cancer with immediate reconstruction of the breast. Surgery,2008,143:414 -425.
|
[30] |
Patani N, Devalia H, Anderson A, et al. Oncological safety and patient satisfaction with skin-sparing mastectomy and immediate breast reconstruction.Surg Oncol, 2008,17:97 -105.
|
[31] |
Recht A,Danoff B S,Solin L J,et al. Intraductal carcinoma of the breast: results of treatment with excisional biopsy and irradiation. J Clin Oncol,1985,3:1339 -1343.
|
[32] |
Wong R K M, Banducci D R, Feldman S, et al. Prereconstruction tattooing eliminated the need for skin grafting in nipple areolar reconstruction. Plast Reconstr Surg,1993,92:547 -549.
|
[33] |
Kurtz J, Jacquemier J, Amalric R, et al. Breast conserving therapy for macroscopically multiple cancers. Ann Surg,1990,212:38 -44.
|
[34] |
Leopold K A, Recht A, Schnitt S J, et al. Results of conservative surgery and radiation therapy for multiple synchronous cancers of one breast. Int J Radiat Oncol Biol Phys,1989,16:11 -16.
|
[35] |
Winchester D P, Cox J D. Standards for breast-conservation treatment. CA Cancer J Clin,1992,42:134 -162.
|
[36] |
Recht A. Patient selection for treatment with conservative surgery and radiation therapy. Cancer Invest, 1992,10:471 -476.
|
[37] |
Fleck R,Mc Neese M D, Ellerbroek N A,et al. Consequences of breast irradiation in patients with pre-existing collagen vascular disease. Int J Radiat Oncol Biol Phys,1989,17:829 -833.
|
[38] |
Robertson J G, Clarke D H, Pevzner M M, et al. Breast conservation therapy: severe breast fibrosis after radiation therapy in patient with collagen-vascular disease. Cancer,1991,68:502 -508.
|
[39] |
Ross J G, Hussey D H, Mayr N A, et al. Acute and late reactions to radiation therapy in patients with collagen vascular diseases. Cancer,1993,71:3744 -3752.
|
[40] |
Recht A. Selection of patients with early stage invasive breast cancer for treatment with conservative surgery and radiation therapy. Semin Oncol,1996,23:19 -30.
|
[41] |
Winchester D P, Cox J D. Standards for diagnosis and management of invasive breast carcinoma. American College of Radiology. American College of Surgeons. College of American Pathologists. Society of Surgical Oncology. CA Cancer J Clin,1998,48:83 -107.
|
[42] |
Marcus J N, Watson P, Page D L, et al. Pathology and heredity of breast cancer in younger women. Monogr Natl Cancer Instit,1994,16:23 -34.
|
[43] |
Chabner E, Nixon A, Gelman R, et al. Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer. J Clin Oncol,1998,16:2045 -2051.
|
[44] |
Claus E B. The genetic epidemiology of breast cancer in younger women. Monogr Natl Cancer Inst,1994,16:49 -53.
|
[45] |
Easton D. Breast cancer genes-what are the real risks? Nat Genet,1997,16:210 -211.
|
[46] |
Narod SA. Modifiers of risk of hereditary breast and ovarian cancer. Nat Rev Cancer,2002,2:113 -123.
|
[47] |
Sakorafas G H, Tsiotou A G. Genetic predisposition for breast cancer from a surgical perspective. Br J Surg,2000,87:149 -162.
|
[48] |
Winchester D P, Cox J D. Standards for diagnosis and management of invasive breast carcinoma. CA Cancer J Clin,1998,48:83 -107.
|
[49] |
Sadowsky N L, Semine A, Harris J R. Breast imaging: a critical aspect of breast conserving treatment. Cancer,1990,65:2113 -2118.
|
[50] |
Monsees B S. Evaluation of breast microcalcifications. Radiol Clin North Am,1995,33:1109 -1121.
|
[51] |
Bhattacharyya M, Ryan D, Carpenter R, et al. Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer. Br J Cancer,2008,98:289-293.
|
[52] |
Van Goethem M, Schelfout K, Kersschot E, et al. MR mammography is useful in the preoperative locoregional staging of breast carcinomas with extensive intraductal component. Eur J Radiol,2007,62:273 -282.
|
[53] |
张保宁,张慧明.我国乳腺癌保乳手术应注意的几个问题.中华医学杂志.2008,88:73 -76.
|
[54] |
Holland R, Connolly J L,Gelman R, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol,1990,8:113 -118.
|
[55] |
Lagios M D, Westdahl P R, Margolin F R, et al. Ductal carcinoma in situ: relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity,lymph node metastases, and short-term treatment failures. Cancer,1982,50:1309 -1314.
|
[56] |
O'Sullivan M J,Li T,Freedman G,et al. The effect of multiple reexcisions on the risk of local recurrence after breast conserving surgery. Ann Surg Oncol,2007,14:3133 -3140.
|
[57] |
McIntosh A, Freedman G, Eisenberg D, et al. Recurrence rates and analysis of close or positive margins in patients treated without re-excision before radiation for breast cancer. Am J Clin Oncol,2007,30:146 -151.
|
[58] |
Zafrani B, Vielh P, Fourquet A, et al. Conservative treatment of early breast cancer: Prognostic value of the ductal in situ component and other pathological variables on local control and survival: Long-term results. Eur J Cancer Clin Oncol,1989,25:1645 -1650.
|
[59] |
Harris J R. Breast-conserving therapy as a model for creating new knowledge in clinical oncology. Int J Radiat Oncol Biol Phys,1996,35:641 -648.
|
[60] |
Horst K C, Smitt M C, Goffinet DR, et al. Predictors of local recurrence after breast-conservation therapy. Clin Breast Cancer,2005,5:425 -438.
|
[61] |
Smitt M C, Nowels K, Carlson R W, et al. Predictors of reexcision findings and recurrence after breast conservation. Int J Radiat Oncol Biol Phys,2003,57:979 -985.
|
[62] |
Fitzal F, Gnant M. Breast conservation: evolution of surgical strategies. Breast J,2006,12(5 Suppl 2):S165 -S173.
|
[63] |
Hunt K K, Ames F C, Singletary S E, et al. Locally advanced noninflammatory breast cancer. Surg Clin North Am,1996,76:393 -410.
|
[64] |
Ogston K N, Miller I D, Payne S, et al. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast,2003,12:320 -327.
|
[65] |
Gralow J R, Burstein H J, Wood W, et al. Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease. J Clin Oncol,2008,26:814 -819.
|
[66] |
Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on localregional disease in women with operable breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol, 1997,15:2483 -2493.
|
[67] |
Fisher B, Wolmark N, Mamounas E, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol,1998,16:2672 -2685.
|
[68] |
van der Hage J A, van de Velde C J, Julien J P, et al.Preoperative chemotherapy in primary operable breast cancer.results from the European Organization for Research and Treatment of Cancer Trial 10902. J Clin Oncol, 2001,19:4224 -4237.
|
[69] |
Wolff A C, Berry D, Carey L A, et al. Research issues affecting preoperative systemic therapy for operable breast cancer. J Clin Oncol,2008,26:806 -813.
|
[70] |
Buchholz T A, Lehman C D, Harris J R, et al. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. J Clin Oncol,2008,26:791 -797.
|